Cineworld H1 earnings preview: can the cinema chain recover?
Cineworld shareholders will be keen to find out how well theatres have recovered since being reopened, but there are still plenty of headwinds that could hamper its ability to bounce back in 2020.
- FTSE 250-listed Cineworld is expected to report a steep fall in revenue and be pushed to a loss in the first half (H1) of 2020 as theatres remained closed for most of the period.
- Focus will be on how it has performed since reopening sites considering it has had to operate at reduced capacity and with a weakened film slate.
- Cineworld chief executive officer (CEO) has said he was ‘very pleasantly surprised’ by the numbers of customers that had returned since reopening.
- But cinemas could be forced to close again if further lockdowns are introduced and film studios continue to delay or pull new blockbuster titles, both of which pose a threat to Cineworld’s ability to recover in H2.
When are Cineworld’s H1 results to be released?
Cineworld will release its H1 results on Thursday 24 September. These results will cover the first six months of 2020.
Cineworld H1 preview: what to expect
Cineworld’s H1 results will be the first chance for investors to find out how theatres have performed since being reopened and how eager audiences have been to return to the big screen.
The company has 787 cinemas spread over 10 countries and it began to welcome back customers in its smallest markets, such as in Poland the Czech Republic, in the middle of June, but it only began to reopen sites in the UK and Ireland at the end of July.
Still, the main focus is on the US, which accounts for over 75% of its earnings following its acquisition of Regal Entertainment in late 2017. It began to reopen US theatres where it could in the first half of August but, as lockdown measures are being managed on a state-by-state basis, many still remain closed – including in major states like New York and California.
We have not had much of an update from Cineworld since it reopened sites, but chief executive Mooky Greidinger told CNBC late last month that many showings had sold out and that customers had returned and felt safe thanks to its measures it had taken to protect against the spread of coronavirus.
This does, however, mean screenings are being run at reduced capacity – possibly at just 60% of pre-pandemic levels – which means sold out showings do provide some confidence that demand is there but are not as impressive as they first seem.
The fact the film slate continues to take a battering will not have helped Cineworld and other theatres in recent weeks. Christopher Nolan’s film ‘Tenet’ has been the only blockbuster release since theatres reopened and the performance has been fair but far from inspiring.
The film, which cost $200 million to make, is thought to have grossed just over $250 million worldwide so far. But many other major titles have been delayed or pulled from the schedule entirely – with Disney deciding to exclusively offer its latest hit Mulan to subscribers of its streaming service Disney+ and cut out the big screen altogether.
The problem is that cinemas need audiences to return to give film studios the confidence to release their big titles, but they need the blockbusters to encourage people to return. This catch-22 could continue to harm Cineworld and the rest of the industry this year and there are fears that the rest of 2020’s big hitters – like Wonder Woman 1984 and the latest Marvel film Black Widow – could be delayed.
One reason a strong recovery is particularly important for Cineworld is its heavy debt load. It ended 2019 with $3.5 billion in net debt and that figure stood at over $7.6 billion when lease liabilities were included, which meant leverage was considerably higher than its 3x adjusted earnings target.
Still, after securing extra liquidity in May, Cineworld said this would ‘provide it with sufficient headroom to support the group even in the unlikely event cinemas remain closed until the end of the year’.
The threat of closure has not gone away. Cineworld’s CEO has already conceded that it has missed out in those US states that remain closed, and the threat of a second lockdown is growing for some countries that are seeing coronavirus cases rise again. This could be catastrophic for the industry, not only because of the lost business. It could further dent confidence among film studios and encourage them to find alternative routes to market, with streaming sites going from strength to strength during the pandemic. Current estimates suggest Cineworld’s H2 will not be much better than H1 in terms of revenue and earnings.
Investors should also look for any news on the legal battles Cineworld is facing during this difficult time. The main one to be concerned about is with Cineplex, which is suing Cineworld after it backed out of buying the Canadian chain when the coronavirus crisis unravelled. In a separate matter, CityAM reported in August that one of Cineworld’s landlords, AEW, was taking the company to court over rent for its UK sites that has been withheld during the pandemic.
Cineworld H1 results: what does the City expect?
Virtually all of Cineworld’s theatres were shut for more than half of the interim period and only started to reopen after H1 came to a close at the end of June, which means the H1 results will not be pretty. A Reuters-compiled consensus shows analysts are expecting revenue to fall by over 54% year-on-year and push the stock to a loss.
Cineworld H1 earnings consensus
|H1 2019 Result||H1 2020 Consensus|
|Revenue||$2.15 billion||$971.07 million|
|Earnings per share (EPS)||$0.12||-$0.04|
Before taking the H1 results into account, analysts don’t have high hopes for Cineworld recovering this year and believe H2 could be much of the same, forecasting H2 revenue of $1.07 billion. That would also be less half the £2.2 billion reported the year before, and cause annual 2020 revenue to fall to £2.34 billion from £4.37 billion in 2019. However, these forecasts are likely to be updated, either up or down, once the H1 results are released.
How to trade Cineworld’s H1 results
Cineworld shares have recovered somewhat since hitting a pandemic-low on March 17, when it traded at just 21.38p. Shares have more than doubled in value to trade at around 43.75p today, but they remain more than 80% below the 220p price it demanded at the start of 2020. For comparison, the FTSE 250 has recovered 31% since hitting a low in March and remains 24% lower than the start of the year.
The release of Cineworld’s H1 results will undoubtedly be a trigger moment for shares. You can speculate as to whether you think Cineworld shares will rise and buy (go long) or, if you think they will fall, sell (go short) using either CFDs or spread bets.
- Create an IG trading account or log in to your existing account
- Enter ‘Cineworld’ or its ticker, ‘CINE.L’ in the search bar and select it
- Choose your position size
- Click on ‘buy’ or ‘sell’ in the deal ticket
- Confirm the trade
If you want to try your trading strategy risk-free then why not try an IG demo account? Plus, you can look to invest in Cineworld shares using an IG share dealing account, whereby you can buy the shares outright from just £3.
Cineworld shares: broker recommendations
Brokers believe that the severe slide in Cineworld’s value this year has been overdone and that the stock is now extremely undervalued. While ratings are mixed, it averages out as a Buy and the 94.38p target price is more than double what Cineworld shares trade at today.
|Number of brokers|
|Average target price||94.38p|
IG client sentiment also supports that view, with 88% of IG clients with open positions on Cineworld currently long and therefore expecting the price to rise, with just 12% short and expecting it to decline.
Where next for Cineworld?
No one is expecting the H1 results to be pretty considering theatres were closed for most of the period, so the focus is on Cineworld’s ability to recover at a time when it must operate at reduced capacity, work with a weakened film slate and face the threat of being closed again if countries experience a second wave of infections.
Cineworld needs a recovery in H2 for the sake of its finances. The company has a large debt load and has already taken action to shore up the balance sheet. Cineworld said it had the resources to survive until the end of 2020 even if its theatres had to stay closed when it secured extra headroom from its lenders in May.
That may mean it could get through an equally difficult H2 if it has to – but this will just push the pressure back until 2021, when it will have far fewer levers to pull. This is considering it is already loaded with debt, has suspended the dividend and taken advantage of government support on both sides of the pond. A weak H2 could lead Cineworld to take more drastic action such as downsizing its estate or cutting jobs.
Cineworld is finding life as a publicly-listed business tough right now, demonstrated by the fact its share price has plunged this year. However, the fall in its share price has been so steep that rumours have started to build that Cineworld could be a takeover target in the near future, either by a big film studio looking to expand vertically within the market or by those that think the company would perform better in private hands in the current climate.
This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.
Act on share opportunities today
Go long or short on thousands of international stocks with spread bets and CFDs.
- Get full exposure for a comparatively small deposit
- Trade on spreads from just 0.1%
- Get greater order book visibility with direct market access
See opportunity on a stock?
Try a risk-free trade in your demo account, and see whether you’re on to something.
- Log in to your demo
- Take your position
- See whether your hunch pays off
See opportunity on a stock?
Don’t miss your chance – upgrade to a live account to take advantage.
- Trade a huge range of popular stocks
- Analyse and deal seamlessly on fast, intuitive charts
- See and react to breaking news in-platform
See opportunity on a stock?
Don’t miss your chance. Log in to take advantage while conditions prevail.
Live prices on most popular markets
You might be interested in…
Find out what charges your trades could incur with our transparent fee structure.
Discover why so many clients choose us, and what makes us a world-leading provider of spread betting and CFDs.
Stay on top of upcoming market-moving events with our customisable economic calendar.